Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an unspecified homeopathic remedy that was evaluated in a randomized, double-blind, placebo-controlled crossover study (NCT00809263) conducted by the Integrative Medicine Institute. The study followed a traditional homeopathic drug proving (HDP) methodology, which aims to establish a 'remedy picture' by documenting temporary symptoms provoked in healthy volunteers. The specific identity of the homeopathic substance was kept blinded from subjects, investigators, and statisticians to maintain the integrity of the proving. The intervention involved a 12C potency solution administered as 10 drops three times daily for seven days. The trial was ultimately withdrawn, and the specific active ingredient and intended therapeutic uses remain undisclosed in publicly available clinical trial records.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on homeopathic remedy-Integrative Medicine Institute.